Clinical Trial Update: A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Participants With Preterm Preeclampsia and Their Children up to 24 Months [Phase 1]

View source ↗

Summary

A Phase 1 trial investigating the safety, pharmacodynamics, and pharmacokinetics of CBP-4888 in hospitalized participants with Preeclampsia or Preterm Preeclamp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia
• Preterm Preeclampsia

Drugs mentioned

• CBP-4888

Snippet

Sponsor: Comanche Biopharma | Conditions: sFlt1 Mediated Preterm Preeclampsia, Preeclampsia | Phase 1 | Status: RECRUITING